165 related articles for article (PubMed ID: 3100705)
1. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
3. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
4. [A study on the significance of bromocriptine (CB-154) administration in normoprolactinemic anovulatory women (author's transl)].
Ishimaru T; Mori H; Koh K; Imamichi S; Morisaki M; Kohno A; Yoshida K; Imamura S; Yamabe T
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1583-90. PubMed ID: 7240824
[TBL] [Abstract][Full Text] [Related]
5. [Effects of bromocriptine on FSH and LH secretion in women with euprolactinemic anovulation (author's transl)].
Mori H; Aisaka K; Kigawa T; Minakuchi H; Sakamoto S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1741-8. PubMed ID: 6796631
[TBL] [Abstract][Full Text] [Related]
6. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
Fukunaga T
Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
[TBL] [Abstract][Full Text] [Related]
7. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
8. PRL action on E2 ovarian secretion.
Polatti F; Nava C; Brambilla A; Zara C
Clin Exp Obstet Gynecol; 1982; 9(3):160-4. PubMed ID: 6819897
[TBL] [Abstract][Full Text] [Related]
9. [The ovulation-inducing effect of CB-154 on normoprolactinemic anovulatory subjects (author's transl)].
Tamura T; Minakami H
Nihon Naibunpi Gakkai Zasshi; 1982 Jan; 58(1):49-62. PubMed ID: 6802683
[TBL] [Abstract][Full Text] [Related]
10. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Hirvonen E; Ranta T; Seppäla M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
[TBL] [Abstract][Full Text] [Related]
11. alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine.
Klibanski A; Beitins IZ; Zervas NT; McArthur JW; Ridgway EC
J Clin Endocrinol Metab; 1983 Apr; 56(4):774-80. PubMed ID: 6187760
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
Prelević GM; Würzburger MI; Perić LA
J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
[TBL] [Abstract][Full Text] [Related]
13. Unusual prolactin response to luteinizing hormone-releasing hormone in some anovulatory women.
Giampietro O; Moggi G; Chisci R; Coluccia A; Luche AD; Simonini N; Brunori I
J Clin Endocrinol Metab; 1979 Jul; 49(1):141-3. PubMed ID: 376544
[TBL] [Abstract][Full Text] [Related]
14. [Effects of bromocriptine on endocrine environment in the polycystic ovary syndrome].
Huang HJ; Ishimaru T; Yamabe T
Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):265-78. PubMed ID: 3136040
[TBL] [Abstract][Full Text] [Related]
15. Relationship between pituitary reserve and efficacy of bromocriptine in women with euprolactinemic ovulatory dysfunction.
Lin KC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 May; 10(5):222-8. PubMed ID: 8040924
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
Seppälä M; Unnérus HA; Hirvonen E; Ranta T
J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
[TBL] [Abstract][Full Text] [Related]
17. [The effects of bromocriptine in normoprolactinemic anovulation and dysovulation: followed by pregnancy in 11 cases].
Vitse M; Boulanger JC; Camier B
Rev Fr Gynecol Obstet; 1984 Dec; 79(12):791-5. PubMed ID: 6531591
[TBL] [Abstract][Full Text] [Related]
18. [The effects of bromocriptine on anovulatory patients with high LH and euprolactinemia].
Mori H; Aisaka K; Matsuoka R; Kigawa T
Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):48-55. PubMed ID: 3922814
[TBL] [Abstract][Full Text] [Related]
19. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of the effect of combination treatment with clomiphene and bromocriptine in patients with normoprolactinemic anovulation.
Yasui T; Irahara M; Shisukawa K; Azuma K; Aono T
J Endocrinol Invest; 1990; 13(7):549-54. PubMed ID: 2121818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
